GALECTIN THERAPEUTICS INC Business Finance Contracts & Agreements

77 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
2020 Deferred Stock Unit Amendment
Stock Agreements
GALECTIN THERAPEUTICS INC
Biotechnology
2022
2023 Deferred Stock Unit Agreement
Stock Agreements
GALECTIN THERAPEUTICS INC
Biotechnology
2022
Form of Convertible Promissory Note
Note Agreements
GALECTIN THERAPEUTICS INC
Biotechnology
2022
Line of Credit Letter Agreement, dated as of July 25, 2022, by and between Richard E. Uihlein and the Company
Credit Agreements
GALECTIN THERAPEUTICS INC
Biotechnology
NV
2022
Form of Warrant
Warrant Agreements
GALECTIN THERAPEUTICS INC
Biotechnology
NV
2022
Unsecured Convertible Promissory Note, dated December 20, 2021
Note Agreements
GALECTIN THERAPEUTICS INC
Biotechnology
GA
2021
Unsecured Convertible Promissory Note, dated September 17, 2021
Note Agreements
GALECTIN THERAPEUTICS INC
Biotechnology
GA
2021
Loan Agreement, dated September 17, 2021
Loan Agreements
GALECTIN THERAPEUTICS INC
Biotechnology
NY
2021
Convertible Promissory Note, dated April 16, 2021
Note Agreements
GALECTIN THERAPEUTICS INC
Biotechnology
GA
2021
Deferred Stock Unit Agreement, dated August 31, 2020, between Galectin Therapeutics Inc. and Joel Lewis
Stock Agreements
GALECTIN THERAPEUTICS INC
Biotechnology
2020
Second Amendment to Line of Credit Letter Agreement, dated January 11, 2019, by and between Richard E. Uihlein and the Company
Credit Agreements
GALECTIN THERAPEUTICS INC
Biotechnology
GA
2019
Form of Amended and Restated 10X Fund Class B Common Stock Purchase Warrant
Warrant Agreements
GALECTIN THERAPEUTICS INC
Biotechnology
DE
2019
Form of Amended and Restated Class B Common Stock Purchase Warrant
Warrant Agreements
GALECTIN THERAPEUTICS INC
Biotechnology
DE
2019
Second Amendment to Common Stock Purchase Warrant, dated January 11, 2019, by and between Richard E. Uihlein and the Company
Warrant Agreements
GALECTIN THERAPEUTICS INC
Biotechnology
2019
First Amendment to Line of Credit Agreement, dated as of December 20, 2018, by and between Richard E. Uihlein and the Company
Credit Agreements
GALECTIN THERAPEUTICS INC
Biotechnology
GA
2019
First Amendment to Common Stock Purchase Warrant, dated December 20, 2018, by and between Richard E. Uihlein and the Company
Warrant Agreements
GALECTIN THERAPEUTICS INC
Biotechnology
2019
Line of Credit Agreement, dated as of December 19, 2017, by and between Richard E. Uihlein and the Company
Credit Agreements
GALECTIN THERAPEUTICS INC
Biotechnology
NV
2017
Form of Common Stock Purchase Warrant
Warrant Agreements
GALECTIN THERAPEUTICS INC
Biotechnology
NV
2017
GALECTIN THERAPEUTICS INC. Common Stock (par value $0.001per share) At Market Issuance Sales Agreement
Stock Agreements
GALECTIN THERAPEUTICS INC
Biotechnology
NJ
2017
SECOND AMENDMENT TOSECURITIES PURCHASE AGREEMENT
Purchase Agreements
GALECTIN THERAPEUTICS INC
Biotechnology
2016
GALECTIN THERAPEUTICS, INC. SUBSCRIPTION AGREEMENT
Subscription Agreements
GALECTIN THERAPEUTICS INC
Biotechnology
GA
2016
GALECTIN THERAPEUTICS, INC. COMMON STOCK PURCHASE WARRANT
Warrant Agreements
GALECTIN THERAPEUTICS INC
Biotechnology
DE
2016
REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreements
GALECTIN THERAPEUTICS INC
Biotechnology
DE
2016
SECURITIES PURCHASE AGREEMENT
Purchase Agreements
GALECTIN THERAPEUTICS INC
Biotechnology
DE
2016
GALECTIN THERAPEUTICS, INC. COMMON STOCK PURCHASE WARRANT CLASS B-3
Warrant Agreements
GALECTIN THERAPEUTICS INC
Biotechnology
DE
2016
GALECTIN THERAPEUTICS, INC. COMMON STOCK PURCHASE WARRANT CLASS B-3
Warrant Agreements
GALECTIN THERAPEUTICS INC
Biotechnology
DE
2016
PROJECT ADDENDUM MODIFICATION
Modification Agreements
GALECTIN THERAPEUTICS INC
Biotechnology
2016
REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreements
GALECTIN THERAPEUTICS INC
Biotechnology
2015
SECURITIES PURCHASE AGREEMENT
Purchase Agreements
GALECTIN THERAPEUTICS INC
Biotechnology
NY
2015
COMMON STOCK PURCHASE WARRANT GALECTIN THERAPEUTICS, INC.
Warrant Agreements
GALECTIN THERAPEUTICS INC
Biotechnology
2015
GALECTIN THERAPEUTICS INC. Common Stock (par value $0.001per share) At Market Issuance Sales Agreement
Stock Agreements
GALECTIN THERAPEUTICS INC
Biotechnology
NY
2013
STOCK OPTION AGREEMENT GALECTIN THERAPEUTICS INC. STOCK OPTION AGREEMENT FOR THOMAS MCGAULEY AGREEMENT
Stock Agreements
GALECTIN THERAPEUTICS INC
Biotechnology
2013
GALECTIN THERAPEUTICS INC. COMMON STOCK PURCHASE WARRANT CLASS B
Warrant Agreements
GALECTIN THERAPEUTICS INC
Biotechnology
DE
2013
GALECTIN THERAPEUTICS INC. COMMON STOCK PURCHASE WARRANT CLASS A-2
Warrant Agreements
GALECTIN THERAPEUTICS INC
Biotechnology
DE
2013
GALECTIN THERAPEUTICS INC. FORM OF WARRANT AGREEMENT
Warrant Agreements
GALECTIN THERAPEUTICS INC
Biotechnology
NY
2012
$10,435,005 of Units GALECTIN THERAPEUTICS INC. Units Consisting of Two Shares of Common Stock and One Warrant to Purchase One Share of Common Stock UNDERWRITING AGREEMENT
Underwriting Agreements
GALECTIN THERAPEUTICS INC
Biotechnology
NY
2012
PRO-PHARMACEUTICALS, INC. NON-QUALIFIED STOCK OPTION AGREEMENT FOR PETER G. TRABER, M.D.
Stock Agreements
GALECTIN THERAPEUTICS INC
Biotechnology
MA
2011
PRO-PHARMACEUTICALS, INC. COMMON STOCK PURCHASE WARRANT CLASS B-1
Warrant Agreements
GALECTIN THERAPEUTICS INC
Biotechnology
DE
2011
PRO-PHARMACEUTICALS, INC. COMMON STOCK PURCHASE WARRANT CLASS A-2
Warrant Agreements
GALECTIN THERAPEUTICS INC
Biotechnology
DE
2011
PRO-PHARMACEUTICALS, INC. COMMON STOCK PURCHASE WARRANT CLASS A-1
Warrant Agreements
GALECTIN THERAPEUTICS INC
Biotechnology
DE
2011